Current controversies: Which patients with acute myeloid leukaemia should receive a bone marrow transplantation? An adult treater's view

被引：45

作者：

Burnett , AK ^{[1
]}

机构：

[1] Cardiff Univ, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 118卷 / 02期

关键词：

AML; transplantation;

D O I：

10.1046/j.1365-2141.2002.03698.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：357 / 364

页数：8

共 48 条

[1]

APPELBAUM FR, 1988, BLOOD, V72, P179

[2] Conditioning regimens for allogeneic stem cell transplants [J].

Barrett, AJ .

CURRENT OPINION IN HEMATOLOGY, 2000, 7 (06) :339-342

[3] REASONS THAT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA DO NOT UNDERGO ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

BERMAN, E ;

LITTLE, C ;

GEE, T ;

OREILLY, R ;

CLARKSON, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (03) :156-160

[4]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[5]

Büchner T, 1999, BLOOD, V93, P4116

[6]

BURNETT AK, 1984, LANCET, V2, P1068

[7] Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].

Burnett, AK ;

Grimwade, D ;

Solomon, E ;

Wheatley, K ;

Goldstone, AH .

BLOOD, 1999, 93 (12) :4131-4143

[8] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].

Burnett, AK ;

Goldstone, AH ;

Stevens, RMF ;

Hann, IM ;

Rees, JKH ;

Gray, RG ;

Wheatley, K .

LANCET, 1998, 351 (9104) :700-708

[9]

Burnett AK, 1999, BRIT J HAEMATOL, V105, P67

[10] UNRELATED DONOR OR AUTOLOGOUS MARROW TRANSPLANTATION FOR TREATMENT OF ACUTE-LEUKEMIA [J].

BUSCA, A ;

ANASETTI, C ;

ANDERSON, G ;

APPELBAUM, FR ;

BUCKNER, CD ;

DONEY, K ;

MARTIN, PJ ;

PETERSDORF, E ;

SANDERS, JE ;

HANSEN, JA .

BLOOD, 1994, 83 (10) :3077-3084

← 1 2 3 4 5 →